Stock A059210 META BIOMED CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Meta Biomed Co., Ltd.

Equities

A059210

KR7059210005

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
4,790 KRW -0.42% Intraday chart for Meta Biomed Co., Ltd. -5.71% +9.86%
Mar. 15 Meta Biomed Co., Ltd.'s Equity Buyback Plan Extended till March 16, 2026. CI
Mar. 11 Meta Biomed Co., Ltd. announced that it has received KRW 24 billion in funding from Mirae Asset Securities Co., Ltd., Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., KB-Suseong No. 1 New Technology Business Investment Association CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 68,950 64,799 64,352 66,184 52,832 99,718
Enterprise Value (EV) 1 94,000 95,169 93,216 84,746 77,763 127,356
P/E ratio -59.5 x 19.4 x -15.8 x 6.95 x 20.1 x 9.89 x
Yield 0.34% 0.36% 0.36% 0.69% 0.87% 0.46%
Capitalization / Revenue 1.08 x 1.09 x 1.36 x 1.13 x 0.77 x 1.2 x
EV / Revenue 1.47 x 1.6 x 1.97 x 1.44 x 1.13 x 1.53 x
EV / EBITDA -145 x 10.1 x 16.1 x 9.6 x 8.46 x 8.59 x
EV / FCF -7.07 x -22.8 x 65.6 x 15 x -12.6 x -38.2 x
FCF Yield -14.1% -4.39% 1.52% 6.67% -7.96% -2.62%
Price to Book 1.37 x 1.22 x 1.34 x 1.13 x 0.87 x 1.42 x
Nbr of stocks (in thousands) 23,492 23,267 22,901 22,901 22,871 22,871
Reference price 2 2,935 2,785 2,810 2,890 2,310 4,360
Announcement Date 3/20/19 3/18/20 3/17/21 3/18/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 63,813 59,391 47,209 58,780 68,942 83,101
EBITDA 1 -649 9,466 5,790 8,832 9,196 14,825
EBIT 1 -4,080 5,753 1,848 5,261 5,336 10,602
Operating Margin -6.39% 9.69% 3.91% 8.95% 7.74% 12.76%
Earnings before Tax (EBT) 1 616.8 5,925 -4,619 7,584 3,988 7,805
Net income 1 -1,148 3,346 -4,093 9,522 2,628 10,080
Net margin -1.8% 5.63% -8.67% 16.2% 3.81% 12.13%
EPS 2 -49.30 143.4 -178.0 415.8 114.8 440.7
Free Cash Flow 1 -13,290 -4,182 1,420 5,650 -6,193 -3,338
FCF margin -20.83% -7.04% 3.01% 9.61% -8.98% -4.02%
FCF Conversion (EBITDA) - - 24.53% 63.97% - -
FCF Conversion (Net income) - - - 59.34% - -
Dividend per Share 2 10.00 10.00 10.00 20.00 20.00 20.00
Announcement Date 3/20/19 3/18/20 3/17/21 3/18/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 25,050 30,370 28,864 18,562 24,931 27,638
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -38.59 x 3.208 x 4.986 x 2.102 x 2.711 x 1.864 x
Free Cash Flow 1 -13,290 -4,182 1,420 5,650 -6,193 -3,338
ROE (net income / shareholders' equity) -2.25% 10.8% -7.84% 17.4% 5.83% 14.7%
ROA (Net income/ Total Assets) -2.35% 3.58% 1.09% 3.12% 2.97% 5.28%
Assets 1 48,929 93,528 -374,138 305,471 88,331 191,065
Book Value Per Share 2 2,142 2,289 2,095 2,547 2,649 3,063
Cash Flow per Share 2 235.0 101.0 377.0 442.0 578.0 472.0
Capex 1 9,081 7,561 2,227 2,067 15,395 11,489
Capex / Sales 14.23% 12.73% 4.72% 3.52% 22.33% 13.83%
Announcement Date 3/20/19 3/18/20 3/17/21 3/18/22 3/21/23 3/21/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
META BIOMED CO., LTD. Stock Meta Biomed Co., Ltd.
+10.32% 80.97M
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.38% 177B
MEDTRONIC PLC Stock Medtronic plc
-0.46% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.98% 65.55B
DEXCOM, INC. Stock DexCom, Inc.
+2.65% 50.66B
CENCORA, INC. Stock Cencora, Inc.
+5.27% 42.58B
HOYA CORPORATION Stock Hoya Corporation
+5.73% 40.74B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+19.92% 31.07B
TERUMO CORPORATION Stock Terumo Corporation
+16.57% 25.45B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-7.00% 23.85B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. A059210 Stock
  4. Financials Meta Biomed Co., Ltd.